396 related articles for article (PubMed ID: 8357468)
21. Activity of capuramycin analogues against Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium intracellulare in vitro and in vivo.
Koga T; Fukuoka T; Doi N; Harasaki T; Inoue H; Hotoda H; Kakuta M; Muramatsu Y; Yamamura N; Hoshi M; Hirota T
J Antimicrob Chemother; 2004 Oct; 54(4):755-60. PubMed ID: 15347635
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and in vitro antimycobacterial activity of N1-nicotinoyl-3-(4'-hydroxy-3'-methyl phenyl)-5-[(sub)phenyl]-2-pyrazolines.
Shaharyar M; Siddiqui AA; Ali MA; Sriram D; Yogeeswari P
Bioorg Med Chem Lett; 2006 Aug; 16(15):3947-9. PubMed ID: 16725324
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and antimycobacterial evaluation of various 7-substituted ciprofloxacin derivatives.
Sriram D; Yogeeswari P; Basha JS; Radha DR; Nagaraja V
Bioorg Med Chem; 2005 Oct; 13(20):5774-8. PubMed ID: 16039859
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and in-vitro antimycobacterial activity of amino-5-[(substituted) phenyl]-3-(4-hydroxy-3-methylphenyl)-4,5-dihydro-1H-1-pyrazolylmethanethione.
Ali MA; Yar MS; Siddiqui AA; Husain A; Abdullah M
Acta Pol Pharm; 2007; 64(5):435-9. PubMed ID: 18540164
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and antituberculosis activity of new hydrazide derivatives.
Kaplancikli ZA; Turan-Zitouni G; Ozdemir A; Teulade JC
Arch Pharm (Weinheim); 2008 Nov; 341(11):721-4. PubMed ID: 18720343
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and in vitro antitubercular activity of a series of quinoline derivatives.
de Souza MV; Pais KC; Kaiser CR; Peralta MA; de L Ferreira M; Lourenço MC
Bioorg Med Chem; 2009 Feb; 17(4):1474-80. PubMed ID: 19188070
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and in vitro anti Mycobacterium tuberculosis activity of a series of phthalimide derivatives.
Santos JL; Yamasaki PR; Chin CM; Takashi CH; Pavan FR; Leite CQ
Bioorg Med Chem; 2009 Jun; 17(11):3795-9. PubMed ID: 19427791
[TBL] [Abstract][Full Text] [Related]
28. In vitro and ex vivo activity of new derivatives of acetohydroxyacid synthase inhibitors against Mycobacterium tuberculosis and non-tuberculous mycobacteria.
Sohn H; Lee KS; Ko YK; Ryu JW; Woo JC; Koo DW; Shin SJ; Ahn SJ; Shin AR; Song CH; Jo EK; Park JK; Kim HJ
Int J Antimicrob Agents; 2008 Jun; 31(6):567-71. PubMed ID: 18337064
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and antimycobacterial activity of some new 3-heterocyclic substituted chromones.
Gasparová R; Lácová M; el-Shaaer HM; Odlerová Z
Farmaco; 1997 Apr; 52(4):251-3. PubMed ID: 9241831
[TBL] [Abstract][Full Text] [Related]
30. [A comparative study of the susceptibilities to antituberculosis agents between Mycobacterium tuberculosis and Mycobacterium avium complex strains].
Tsukamura M
Kekkaku; 1987 Jun; 62(6):345-8. PubMed ID: 3116312
[No Abstract] [Full Text] [Related]
31. [In vitro activities of rifabutine and rifampicin against various mycobacteria, especially Mycobacterium tuberculosis and Mycobacterium avium complex].
Saito H; Sato K; Tomioka H
Kekkaku; 1988 Mar; 63(3):167-72. PubMed ID: 2836649
[No Abstract] [Full Text] [Related]
32. Synthesis, biological evaluation and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis.
Castagnolo D; De Logu A; Radi M; Bechi B; Manetti F; Magnani M; Supino S; Meleddu R; Chisu L; Botta M
Bioorg Med Chem; 2008 Sep; 16(18):8587-91. PubMed ID: 18752962
[TBL] [Abstract][Full Text] [Related]
33. Antimycobacterial activity of substituted isosteres of pyridine- and pyrazinecarboxylic acids.
Wächter GA; Davis MC; Martin AR; Franzblau SG
J Med Chem; 1998 Jun; 41(13):2436-8. PubMed ID: 9632376
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and antituberculosis activity of a novel series of optically active 6-nitro-2,3-dihydroimidazo[2,1-b]oxazoles.
Sasaki H; Haraguchi Y; Itotani M; Kuroda H; Hashizume H; Tomishige T; Kawasaki M; Matsumoto M; Komatsu M; Tsubouchi H
J Med Chem; 2006 Dec; 49(26):7854-60. PubMed ID: 17181168
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and antimycobacterial evaluation of N-substituted 3-aminopyrazine-2,5-dicarbonitriles.
Zitko J; Jampílek J; Dobrovolný L; Svobodová M; Kuneš J; Doležal M
Bioorg Med Chem Lett; 2012 Feb; 22(4):1598-601. PubMed ID: 22281187
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and tuberculostatic activity of some derivatives of imidazo [4, 5-b]pyridine-1-carboxylic acid.
Bukowski L
Pol J Pharmacol Pharm; 1984; 36(6):683-8. PubMed ID: 6442935
[TBL] [Abstract][Full Text] [Related]
37. Antituberculous activity of new 2- and 5-substituted delta2-thiazolin-4-ones.
Peciura R; Tarasevicius E; Martinkus R; Sosnovskaya A
Pharmazie; 1981 Dec; 36(12):862-3. PubMed ID: 6799970
[No Abstract] [Full Text] [Related]
38. Anti-tubercular agents. Part IV: Synthesis and antimycobacterial evaluation of nitroheterocyclic-based 1,2,4-benzothiadiazines.
Kamal A; Ahmed SK; Reddy KS; Khan MN; Shetty RV; Siddhardha B; Murthy US; Khan IA; Kumar M; Sharma S; Ram AB
Bioorg Med Chem Lett; 2007 Oct; 17(19):5419-22. PubMed ID: 17692520
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and in vitro antimycobacterial activity of 3-substituted 5-hydroxy-5-trifluoro[chloro]methyl-4,5-dihydro-1H-1-(isonicotinoyl) pyrazoles.
Almeida da Silva PE; Ramos DF; Bonacorso HG; de la Iglesia AI; Oliveira MR; Coelho T; Navarini J; Morbidoni HR; Zanatta N; Martins MA
Int J Antimicrob Agents; 2008 Aug; 32(2):139-44. PubMed ID: 18571384
[TBL] [Abstract][Full Text] [Related]
40. Some reactions of 2-cyanomethyl-3-methyl-3H-imidazo[4,5-b]pyridine with isothiocyanates. Antituberculotic activity of the obtained compounds.
Bukowski L
Pharmazie; 2001 Jan; 56(1):23-7. PubMed ID: 11210662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]